Laura A. Doorley

Abrogation of Triazole Resistance upon Deletion of <i>CDR1</i> in a Clinical Isolate of <i>Candida auris</i>

Jeffrey M. Rybak, Laura A. Doorley, Andrew T. Nishimoto et al. · Antimicrobial Agents and Chemotherapy · 2019 · 147 citations · Full text

Delineation of the Direct Contribution of Candida auris <i>ERG11</i> Mutations to Clinical Triazole Resistance

Jeffrey M. Rybak, Cheshta Sharma, Laura A. Doorley et al. · Microbiology Spectrum · 2021 · 62 citations · Full text

Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance

Laura A. Doorley, Jeffrey M. Rybak, Elizabeth L. Berkow et al. · Antimicrobial Agents and Chemotherapy · 2022 · 34 citations · Full text

Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis

Laura A. Doorley, Katherine S. Barker, Qing Zhang et al. · Clinical Microbiology and Infection · 2023 · 21 citations · Full text

Antifungal Agent, Health Sciences, Antifungal Agents +13

Humoral immune responses during asthma and influenza co-morbidity in mice

Laura A. Doorley, Kim S. LeMessurier, Amy Iverson et al. · Immunobiology · 2017 · 16 citations · Full text

Asthma, Inflammation, Humoral Immune Responses +7